Advancing Antisense Oligonucleotides For Personalized Medicine

Given the potential of ASOs to treat rare genetic disorders, these efforts could yield breakthrough results for life sciences innovators and the patients they serve.

Related Keywords

Barcelona ,Comunidad Autonoma De Cataluna ,Spain , ,Oligonucleotide Therapeutics Society ,Delivery Technology ,Development And Manufacturing ,European Medicines Agency ,Forbes Technology Council ,Therapeutics Society ,Requirements For ,Disease Treatment ,Technology Council ,Demaris Mills ,